Vitro SAB de CV (VITROA) Financial Statements
Vitro SAB de CV Financial Overview
Vitro SAB de CV's market cap is currently $2.27B. The company's EPS TTM is $0.34; its P/E ratio is 0.73; Vitro SAB de CV has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 300.37M | $ 284.15M | $ 310.65M | $ 251.81M | $ 1.96B |
| Gross Profit | $ 109.62M | $ 120.05M | $ 150.96M | $ 140.87M | $ 396.01M |
| Operating Income | $ 6.20M | $ 12.80M | $ 41.13M | $ 31.32M | $ -8.89M |
| EBITDA | $ 33.16M | $ 18.08M | $ 202.01M | $ 114.94M | $ 204.96M |
| Net Income | $ 138.05M | $ -96.61M | $ 128.87M | $ 17.86M | $ -106.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 24.33M | $ 26.86M | $ 37.61M | $ 122.70M | $ 110.12M |
| Total Assets | $ 1.31B | $ 1.33B | $ 1.64B | $ 2.56B | $ 2.54B |
| Total Debt | $ 159.18M | $ 398.51M | $ 445.29M | $ 743.35M | $ 733.33M |
| Net Debt | $ 134.85M | $ 371.65M | $ 407.68M | $ 620.65M | $ 623.21M |
| Total Liabilities | $ 634.89M | $ 695.39M | $ 965.25M | $ 1.35B | $ 1.34B |
| Stockholders' Equity | $ 671.96M | $ 633.38M | $ 672.56M | $ 1.21B | $ 1.20B |
| Cash Flow | |||||
| Free Cash Flow | $ 139.60M | $ 62.35M | $ 255.13M | $ 105.10M | $ -125.77M |
| Operating Cash Flow | $ 162.92M | $ 76.56M | $ 272.51M | $ 274.62M | $ -24.90M |
| Investing Cash Flow | $ -43.44M | $ 71.71M | $ -83.28M | $ -186.28M | $ -80.52M |
| Financing Cash Flow | $ -123.23M | $ -156.64M | $ -120.26M | $ -73.83M | $ -266.38M |
Currency in USD
